Posted: February 7th, 2013 | Author: Michael Courtenay | Filed under: Cankler Science News | Tags: Australian Heart Foundation, Cankler Science News, Erectile Dysfunction, Heart Disease, Medical Research, Sax Institute 45 Up Study, the Sax Institute | Comments Off
New Australian research has found men suffering even mild erectile dysfunction could have heart disease without knowing it. The Sax Institute’s 45 and Up Study is one of the largest on-going studies of healthy ageing in the world.
Doctors who looked at more than 95,000 men found that erectile dysfunction may be a symptom of cardiovascular disease. The study found that men with erectile dysfunction have a higher risk of being admitted to hospital with heart disease, even if they have no history of heart problems.
This is because erectile dysfunction can indicate problems with blood vessels and poor blood flow. The study notes that erectile dysfunction is common, with an estimated 40 per cent of men over 40 experiencing it :: Read the full article »»»»
Posted: November 11th, 2012 | Author: M.Aaron Silverman | Filed under: Cankler Science News | Tags: Aspirin, Autumn Crocus, Cankler Science News, Colchicine, Colchicum Autumnale, Familial Mediterranean Fever, Gout, Heart Attack Medication, Heart Attack Preventative, Meadow Saffron, Medical Research | Comments Off
A West Australian-led study has found a person’s risk of heart attack could be dramatically reduced by taking a common medication to treat gout. More than 500 people participated in the Heart Research Institute study at Perth’s Sir Charles Gairdner Hospital.
Some participants were given the Gout treatment/medication Colchicine. It’s a toxic natural product and secondary metabolite, originally extracted from plants of the genus Colchicum, Meadow Saffron, Autumn Crocus, Colchicum Autumnale.
Colchicine has been used originally to treat rheumatic complaints, especially gout, and still finds use for these purposes today despite dosing issues concerning its toxicity. It’s also prescribed for its cathartic and emetic effects.
In addition to gout, colchicine is use to treat familial Mediterranean fever, pericarditis, and Behçet’s disease. It is also being investigated for its use as an anticancer drug, it’s use as a heart attack preventative is a first :: Read the full article »»»»
Posted: November 9th, 2012 | Author: M.Aaron Silverman | Filed under: Cankler Science News | Tags: Alzheimer Early Prediction, Alzheimer's, Alzheimer's Disease International, Banner Alzheimer's Institute, Brain Scan, Cankler Science News, Early Detection, Medical Research, MRI | Comments Off
Researchers say they have seen the earliest ever warning signs of Alzheimer’s disease among a high-risk group of 20-somethings in the ongoing quest for early detection and prevention. A major problem in the search for a cure for this debilitating form of dementia is that symptoms appear years after irreversible brain decay has already set in.
For the study, a team of scientists from the United States and Colombia tested 18- to 26-year-old members of an extended Colombian family that share a common ancestor and a genetic predisposition to develop an inherited form of Alzheimer’s. One-in-three members of the clan carry a gene mutation that will lead to a rare form of the disease which hits people in their 40s, unlike the common variant which presents much later.
A brain scan comparison found that individuals who carry the errant gene have less grey matter in certain areas of the brain than those who do not, scientists wrote in The Lancet medical journal :: Read the full article »»»»
Posted: October 26th, 2012 | Author: Marcus Dangerfield | Filed under: Cankler Science News | Tags: Cancer Research, Cankler Science News, Garvin Institute, International Cancer Genome Consortium, Medical Research, Mutated Genes, Pancreatic Cancer, Personalised Medicine | Comments Off
Australian scientists have identified a set of mutated genes responsible for pancreatic cancer – one of the most lethal forms of cancer, with very few treatment options – a finding that could lead to early detection and better treatment of the disease.
Pancreatic cancer is highly aggressive and has the highest death rate of the major cancerous diseases, with patients normally dying within months of diagnosis. The researchers say that the genetic sequencing of the DNA of tumours and patients will go into global database known as the International Cancer Genome Consortium – ICGC – which will assist researchers from around the globe in comparing the success and failure of drug treatments and other therapies.
Professor Andrew Biankin from the Kinghorn Cancer Centre at Sydney’s Garvin Institute and co-author of a study appearing in the scientific journal Nature, says treating pancreatic cancer is a race against time :: Read the full article »»»»
Posted: March 24th, 2012 | Author: Michael Courtenay | Filed under: Medical Research, Science | Tags: Australian Researchers, Cerebral Palsy Alliance, Cerebral Palsy Prevention, Magnesium Sulphate, Medical Research, The Royal Australasian College of Obstetricians | Comments Off
The risk of premature babies developing cerebral palsy is cut by a third if the mother is given magnesium sulphate immediately before birth, new research shows. So far it’s only been proven to work in babies born before 30 weeks, however, advocates of the research are saying that this new approach could prevent up to 150 babies a year from developing the chronic life-long condition.
Doctors are hailing the development as the biggest breakthrough in preventing the debilitating condition in 50 years, despite the fact it is not yet being routinely used in hospitals. The benefits of magnesium sulphate had been observed for a while, but obstetrics Professor Caroline Crowther says it was a large study in Australia and New Zealand in 2003 that gave compelling evidence. Read the full article »»»»
Posted: November 10th, 2011 | Author: Michael Courtenay | Filed under: Medical Research, Science, Science News | Tags: Florey Neuroscience Institutes, Medical Research, Parkinsons Disease, Stem Cell, Stem Cells Australia, University of Melbourne | Comments Off
Australian scientists have developed a new technique using stem cells, in the hope to replace damaged cells in Parkinson’s disease. The technique could be developed for application in other degenerative conditions.
Researchers at the University of Melbourne have made a breakthrough in the use of stem cells to treat Parkinson’s disease.Stem cells can be used to allow the body to produce dopamine, which prevents Parkinson’s.Until now, treatment has been too risky because some of the stem cells can become carcinogenic. Scientists have now found a way to identify and separate the therapeutic cells from the dangerous ones.
“We have made some recent progress in that area by identifying novel molecules on the therapeutic cells that allow us to target them and essentially pull them out and purify them,” said Dr Lachlan Thompson of the University of Melbourne. ”I think that will really potentially be an important breakthrough on the road to clinical translation. Read the rest of this entry »»»